Epkinly Approved as Third-Line Treatment for Diffuse Large B-Cell Lymphoma in Korea

A New Treatment Option Emerges for Non-Hodgkin’s Lymphoma

A new treatment option for managing refractory blood cancer, specifically Diffuse Large B-Cell Lymphoma (DLBCL), has completed its approval process in Korea. This approval primarily…

Shin Dong-kuk "Discussing Responsibility Management and Professional Management Integration with Two Brothers"

Hanmi Pharmaceutical Group Declares End to Management Dispute

The management dispute within Hanmi Pharmaceutical Group that has heated up the pharmaceutical and biotech industry for over 6months this year has come to an end. On the 10th, Lim Jong-yoon, an…

K-CAB's U.S. Phase 3 Clinical Trial Results Expected in the Second Half

Reasons to Watch HK Inno.N in the Second Half of the Year

HK Inno.N Corporation is emerging as a company to watch in the second half of the year, following strong performance and promising U.S. clinical trial results. On the 9th, the securities industry…

Supporting a professional management system led by Hanyang Precision Chairman Shin Dong-guk

Song Young-sook to step down as chairwoman of Hanmi Pharm

Song Young-sook, chairwoman of Hanmi Pharm. Co., Ltd. has stepped down from the management of the company and said he will support a professional management system centred on Hanyang Precision…